%0 Journal Article %1 dejessascenciomontiel2022multimodal %A de Jesús Ascencio-Montiel, Iván %A Tomás-López, Juan Carlos %A Álvarez-Medina, Verónica %A Gil-Velázquez, Luisa Estela %A Vega-Vega, Hortensia %A Vargas-Sánchez, Héctor Raúl %A Cervantes-Ocampo, Manuel %A Villasís-Keever, Miguel Ángel %A González-Bonilla, Cesar Raúl %A Duque-Molina, Célida %D 2022 %J Archives of Medical Research %K covid-19 ivermectin %R 10.1016/j.arcmed.2022.01.002 %T A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19 %U https://www.sciencedirect.com/science/article/pii/S0188440922000029 %X ABSTRACT Background Different interventions have been implemented worldwide for the house-hold monitoring of patients with mild COVID-19 to reduce the burden of healthcare systems and guarantee quality of care. Telephone follow up and treatment kits have not been evaluated in the context of a national-wide primary care program. Aim of the study To compare the risk of hospitalization and death for COVID-19 between ambulatory patients who received and those who did not receive a treatment kit and telephone follow-up in a developing country Methods A two-group comparative analysis was conducted using data from the medical information systems of the Mexican Institute of Social Security. We included a total of 28,048 laboratory-confirmed SARS-CoV-2 patients: 7,898 (28.2%) received a medical kit and 20,150 (71.8%) did not. The incidence rates of hospitalization and death combined were calculated. To identify significant associations between hospitalization or death and treatment medical kits, we calculated the risk ratios using a multivariate logistic model. Results The incidence of hospitalization was 6.14% in patients who received a kit and 11.71% in those who did not. Male sex, age, and a medical history of obesity, hypertension, diabetes, immunosuppression, or kidney disease were associated with increased risk of hospitalization or death. The risk rates were reduced in patients who received a medical kit or telephone follow-up. In the multivariate model, receiving a medical kit was associated with a lower risk of hospitalization or death from COVID-19: adjusted risk ratio 0.35 (95% confidence interval 0.30–0.40). Conclusion Use of a multimodal strategy may reduce the risk of hospitalization and death in adult outpatients with mild COVID-19.

@article{dejessascenciomontiel2022multimodal, abstract = {ABSTRACT Background Different interventions have been implemented worldwide for the house-hold monitoring of patients with mild COVID-19 to reduce the burden of healthcare systems and guarantee quality of care. Telephone follow up and treatment kits have not been evaluated in the context of a national-wide primary care program. Aim of the study To compare the risk of hospitalization and death for COVID-19 between ambulatory patients who received and those who did not receive a treatment kit and telephone follow-up in a developing country Methods A two-group comparative analysis was conducted using data from the medical information systems of the Mexican Institute of Social Security. We included a total of 28,048 laboratory-confirmed SARS-CoV-2 patients: 7,898 (28.2%) received a medical kit and 20,150 (71.8%) did not. The incidence rates of hospitalization and death combined were calculated. To identify significant associations between hospitalization or death and treatment medical kits, we calculated the risk ratios using a multivariate logistic model. Results The incidence of hospitalization was 6.14% in patients who received a kit and 11.71% in those who did not. Male sex, age, and a medical history of obesity, hypertension, diabetes, immunosuppression, or kidney disease were associated with increased risk of hospitalization or death. The risk rates were reduced in patients who received a medical kit or telephone follow-up. In the multivariate model, receiving a medical kit was associated with a lower risk of hospitalization or death from COVID-19: adjusted risk ratio 0.35 (95% confidence interval 0.30–0.40). Conclusion Use of a multimodal strategy may reduce the risk of hospitalization and death in adult outpatients with mild COVID-19.}, added-at = {2022-02-02T21:50:27.000+0100}, author = {{de Jesús Ascencio-Montiel}, Iván and Tomás-López, Juan Carlos and Álvarez-Medina, Verónica and Gil-Velázquez, Luisa Estela and Vega-Vega, Hortensia and Vargas-Sánchez, Héctor Raúl and Cervantes-Ocampo, Manuel and Villasís-Keever, Miguel Ángel and González-Bonilla, Cesar Raúl and Duque-Molina, Célida}, biburl = {https://www.bibsonomy.org/bibtex/2b8a9a65aba0bf2780266e75153b0a7f2/fordham1}, description = {A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19 - ScienceDirect}, doi = {10.1016/j.arcmed.2022.01.002}, interhash = {8f69b3958b20527ebdcf7d35bbf91314}, intrahash = {b8a9a65aba0bf2780266e75153b0a7f2}, issn = {0188-4409}, journal = {Archives of Medical Research}, keywords = {covid-19 ivermectin}, timestamp = {2022-02-02T21:50:27.000+0100}, title = {A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19}, url = {https://www.sciencedirect.com/science/article/pii/S0188440922000029}, year = 2022 }